Covid-19 Vaccination among Pregnant Woman
DOI:
https://doi.org/10.53089/medula.v11i4.300Keywords:
Covid-19, Vaccine, Pregnant womanAbstract
Coronavirus disease 2019 is an acute respiratory syndrome that causes severe, moderate or mild symptoms. This infection is susceptible in pregnant women and it is associated with the risk of morbidity and mortality both in mother and baby such as intensive care unit, preeclampsia, infection and premature birth and low birth weight. This condition can be prevented by administering the covid-19 vaccine to pregnant women. The covid-19 vaccine is divided into three types based on the mechanism of action, which are mRNA, viral vector and recombinant protein antigen. Four covid-19 vaccines are approvedfor use in the UK; the Pfizer-BioNTech vaccine, the Oxford-AstraZeneca vaccine, the Moderna vaccine and the Janssen vaccine. The vaccine recommended for pregnant women in Indonesia is the Sinovac vaccine which uses the inactivated COVID-19 virus to trigger an immunological response in host cells.
References
World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it; 2020.
Burhan E, Isbaniah F, Susanto AD., dkk. Pneumonia covid-19 diagnosis & penatalaksanaan di Indonesia. Perhimpunan Dokter Paru Indonesia; 2020.
Qiao J. What are the risks of covid-19 infection in pregnant women?. The lancet. 2020;395(1);760–762.
Villar J, Ariff S, Gunier RB., dkk. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817–826.
Chmielewska B, Barratt I, Townsend R., dkk. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(6):759–772.
Savasi VM, Parisi F, Patanè L., dkk. Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2020;136(2):252–258.
Vivanti AJ, Vauloup-Fellous C, Prevot S., dkk. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11(1):1–7.
American College of Obstetricians and Gynecologists (ACOG). ACOG and SMFM Recommend COVID-19 Vaccination for Pregnant Individuals; 2021.
Kementerian Kesehatan Republik Indonesia. 2014. Buku Ajar Imunisasi. Jakarta: Pusat Pendidikan dan Pelatihan Tenaga Kesehatan.
Royal College of Obstetricians & Gynaecologists. Coronavirus (COVID 19) vaccination in pregnancy; 2021.
Perkumpulan Obstetri dan Ginekologi Indonesia. Rekomendasi POGI terkait dengan melonjaknya kasus ibu hamil dengan covid-19 dan perlindungan terhadap tenaga kesehatan. POGI; 2021.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, DKK. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. 2020;370(1): 1-18
Delahoy M, Whitaker M, O’Halloran A, Chai SJ, Kirley PD, Alden N, DKK. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 d COVID-NET, 13 states, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347–1354.
Smithgall MC, Liu-Jarin X, Hamele-Bena D, Cimic A, Mourad M, Debelenko L, DKK. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology. 2020;77(6):994–999.
Benhamou D, Keita H, Ducloy-Bouthors AH. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesth Crit Care Pain Med. 2020; 39(3):351-353
Garg I, Shekhar R, Sheikh AB, Pal S. COVID-19 vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines. Infect Dis Rep. 2021; 13(3):685-699
Understanding how COVID-19 vaccines work. Centers for Disease Control and Prevention; 2020.
Kaur SP, Gupta V. COVID-19 Vaccine: Acomprehensive status report. Virus Res. 2020;288(1):1–13.
Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41(2):1141–1149.
FDA. Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement; 2020.
CDC. Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers—Eight U.S. Locations, December 2020–March 2021. Morb. Mortal Wkly Rep; 2021.
CDC. Thrombosis with Thrombocytopenia Syndrome (TTS) Following Janssen COVID-19 Vaccine. 2021.
CDC. J&J/Janssen Update. 2021.
Drees J. CDC to deploy smartphone app for monitoring individuals’ health post COVID-19 vaccination. Becker’s Healthcare; 2020.
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, DKK. CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary Findings of mRNA covid-19 vaccine safety in pregnant persons. N Engl J Med; 2021.
Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, DKK. Coronavirus disease 2019 vaccine response in pregnant and lactating women: A cohort study. Am J Obstet Gynecol. 2021; 225(3):303.e1-303.e17.
WHO (World Health Organization). Interim recommendations on the use of inactivated Covid-19 vaccine, Coronavac, developed by Sinovac. 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
